ArcticZymes Technologies ASALTS:0DRV 76 Median PS Value is kr22.52 as of Jun. 29, 2026, which is 100% below its 10-year median of 1.36. GuruFocus rates LTS:0DRV with a GF Score™ of 76/100 and a GF Value™ of kr25.75 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 277 Biotechnology companies, ArcticZymes Technologies ASA ranks worse than 70.04% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for ArcticZymes Technologies ASA's Median PS Value or its related term are showing as below:
LTS:0DRV'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.64 Med: 1.36 Max: 6.74
Current: 0.93
During the past 13 years, the highest Price to Median PS Value of ArcticZymes Technologies ASA was 6.74. The lowest was 0.64. And the median was 1.36.
LTS:0DRV's Price-to-Median-PS-Value is ranked worse than 70.04% of 277
companies
in the Biotechnology industry
Industry Median: 0.62
vs LTS:0DRV: 0.93
ArcticZymes Technologies ASA (LTS:0DRV) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
ArcticZymes Technologies ASA's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
20.90
/
22.52
=
0.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA Median PS Value Related Terms
ArcticZymes Technologies ASA Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA Median PS Value Chart
LTS:0DRV vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, ArcticZymes Technologies ASA's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ArcticZymes Technologies ASA Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where ArcticZymes Technologies ASA's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 10.255.
ArcticZymes Technologies ASA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.196.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA (LTS:0DRV) has a Median PS Value of kr22.52 as of Jun. 29, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on ArcticZymes Technologies ASA and its competitors. This is 1556% above median its historical median of 1.36. Over the past decade, ArcticZymes Technologies ASA's Median PS Value has ranged from 0.64 to 6.74. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #194 out of 277 companies in the Biotechnology industry, placing it in the top 70%.
Is ArcticZymes Technologies ASA's Median PS Value too high?
ArcticZymes Technologies ASA's current Median PS Value of kr22.52 is 1556% above median its 10-year median of 1.36. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 6.74. Based on the distribution chart, ArcticZymes Technologies ASA ranks #194 out of 277 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ArcticZymes Technologies ASA has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #194 out of 277 companies for Median PS Value. This places ArcticZymes Technologies ASA in the lower half of its industry. The industry median Median PS Value is 0.62. Historically, ArcticZymes Technologies ASA's own Median PS Value has ranged from 0.64 to 6.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.62, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on ArcticZymes Technologies ASA and its competitors. For the Biotechnology industry, the median Median PS Value is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ArcticZymes Technologies ASA's current Median PS Value is kr22.52, which is 1556% above median its own 10-year median of 1.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr25.75, compared to a current price of kr20.90 — trading 18.8% below its estimated fair value. The current Median PS Value is kr22.52, which is 1556% above median its 10-year median of 1.36. ArcticZymes Technologies ASA's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Median PS Value is kr22.52 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued.
The current stock price of kr20.90 is trading 18.8% below its estimated GF Value™ of kr25.75.
GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.
Key valuation signals for LTS:0DRV:
Median PS Value: kr22.52 (1556% above median its 10-year median of 1.36)
GF Value™: kr25.75 vs. price of kr20.90 (18.8% below fair value)
No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
76GF Score
Get the complete analysis for LTS:0DRV
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DRV has been successfully added to your 
